| All patients (n = 128) | +IDC (n = 91) | -IDC (n = 37) | P Value |
---|---|---|---|---|
Age (years): Median | 68 | 62 | 66 | 0.203 |
IQR | 59–78 | 43–75 | 47–77 | |
Male: n (%) | 69 (53.9) | 51 (56.0) | 18 (48.6) | 0.572 |
Comorbidities and medical history: n (%) | ||||
 Charlson comorbidity index (severe, score ≥ 5) | 78 (60.9) | 50 (54.9) | 28 (75.7) | 0.048 |
 Haematological malignancy | 46 (35.9) | 35 (38.5) | 11 (29.7) | 0.465 |
 Solid organ tumour | 28 (21.9) | 18 (19.8) | 10 (27.0) | 0.507 |
 Diabetes | 22 (17.2) | 13 (14.3) | 9 (24.3) | 0.269 |
 Liver cirrhosis | 15 (11.7) | 12 (13.2) | 3 (8.1) | 0.612 |
 Renal insufficiency | 25 (19.5) | 20 (22.0) | 5 (13.5) | 0.396 |
 Heart failure | 9 (7.0) | 4 (4.4) | 5 (13.5) | 0.148 |
 Immunosuppressed | 86 (67.2) | 59 (64.8) | 27 (73.0) | 0.496 |
Admitting Teams: n (%) | Â | Â | Â | 0.455 |
 Hematology | 48 (37.5) | 36 (39.6) | 12 (32.4) | |
 General medicine | 31 (24.2) | 19 (20.9) | 12 (32.4) | |
 Medical oncology | 26 (20.3) | 18 (19.8) | 8 (21.6) | |
 Renal medicine | 5 (3.9) | 3 (3.3) | 2 (5.4) | |
 Urology | 5 (3.9) | 5 (5.5) | 0 (0) | |
 Other a | 13 (10.2) | 9 (9.9) | 4 (10.8) |